Vigil Neuroscience Stock Analysis

Vigil Stock Analysis Notes

About 18.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.23. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vigil Neuroscience recorded a loss per share of 2.07. The entity had not issued any dividends in recent years. Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Vigil Neuroscience, Inc. operates as a subsidiary of Amgen Inc. Vigil Neuroscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people. For more information please call Ivana JD at 857 254 4445 or visit https://www.vigilneuro.com.

Vigil Neuroscience Investment Alerts

Vigil Neuroscience Upcoming and Recent Events

Vigil Largest EPS Surprises

View All Earnings Estimates

Vigil Neuroscience Thematic Classifications

Vigil Stock Institutional Investors

Note, although Vigil Neuroscience's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vigil Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 88.21 M.

Vigil Profitablity

Management Efficiency

Vigil Neuroscience has return on total asset (ROA) of (0.4336) % which means that it has lost $0.4336 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8969) %, meaning that it created substantial loss on money invested by shareholders. Vigil Neuroscience's management efficiency ratios could be used to measure how well Vigil Neuroscience manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.75. The value of Return On Capital Employed is expected to slide to -1.13. At this time, Vigil Neuroscience's Other Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.12 this year, although the value of Return On Tangible Assets will most likely fall to (0.75).

Technical Drivers

As of the 24th of March, Vigil Neuroscience has the Coefficient Of Variation of 9953.8, semi deviation of 5.05, and Risk Adjusted Performance of 0.0172. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vigil Neuroscience, as well as the relationship between them. Please validate Vigil Neuroscience downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to decide if Vigil Neuroscience is priced more or less accurately, providing market reflects its prevalent price of 1.89 per share. Please also confirm Vigil Neuroscience total risk alpha, which is currently at 0.4323 to double-check the company can sustain itself at a future point.

Vigil Neuroscience Price Movement Analysis

Vigil Neuroscience Insider Trading Activities

Vigil Neuroscience Outstanding Bonds

Vigil Neuroscience Predictive Daily Indicators

Vigil Neuroscience Forecast Models

Vigil Neuroscience's time-series forecasting models are one of many Vigil Neuroscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vigil Neuroscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vigil Neuroscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vigil shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vigil Neuroscience. By using and applying Vigil Stock analysis, traders can create a robust methodology for identifying Vigil entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vigil analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vigil analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Vigil Neuroscience stock analysis indicators help investors evaluate how Vigil Neuroscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vigil Neuroscience shares will generate the highest return on investment. By understating and applying Vigil Neuroscience stock analysis, traders can identify Vigil Neuroscience position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vigil Neuroscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.